HBL Hadasit Bio Holdings

Summary

HBL Hadasit Bio Holdings is the famous Corporate Investor, which was founded in 2005. The leading representative office of defined Corporate Investor is situated in the Jerusalem. The venture was found in Asia in Israel.

When the investment is from HBL Hadasit Bio Holdings the average startup value is 50-100 millions dollars. The fund is generally included in less than 2 deals every year. The important activity for fund was in 2009. Considering the real fund results, this Corporate Investor is 6 percentage points less often commits exit comparing to other organizations. Comparing to the other companies, this HBL Hadasit Bio Holdings performs on 15 percentage points less the average number of lead investments. The increased amount of exits for fund were in 2019. Deals in the range of 1 - 5 millions dollars are the general things for fund.

Among the most successful fund investment fields, there are Health Care, Pharmaceutical. For fund there is a match between the location of its establishment and the land of its numerous investments - Israel. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight ProtAb, KAHR medical, KAHR medical.

This organization was formed by Rafi Hofstein.

The standard case for the fund is to invest in rounds with 1-2 partakers. Despite the HBL Hadasit Bio Holdings, startups are often financed by Sanofi Aventis, Shai Novik, Korea Investment Partners. The meaningful sponsors for the fund in investment in the same round are Sanofi Aventis, Korea Investment Partners, Pontifax. In the next rounds fund is usually obtained by Korea Investment Partners, Sanofi Aventis, Mirae Asset Venture Investment.